Verapamil toxicity dysregulates the phosphatidylinositol 3-kinase pathway

Academic Emergency Medicine

Volumn 15, Issue 4, 2008, Pages 368-374

  Bechtel, Laura K ^a   Haverstick, Doris M ^a   Holstege, Christopher P ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Akt; Calcium channel blockers; Glucose transporter protein; High dose insulin therapy; Phosphatidylinositol 3 kinase; Verapamil

Indexed keywords

BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DILTIAZEM; GLUCOSE; INSULIN; INSULIN RECEPTOR; NIFEDIPINE; PHENYLALKYLAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SERINE; SOMATOMEDIN RECEPTOR; VERAPAMIL; ANDROSTANE DERIVATIVE; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG INTOXICATION; DRUG MECHANISM; ENZYME ACTIVITY; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; ADIPOCYTE; ANIMAL; CELL CULTURE; METABOLISM; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOCYTES; ANDROSTADIENES; ANIMALS; BLOTTING, WESTERN; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; DILTIAZEM; GLUCOSE; INSULIN; MICE; NIFEDIPINE; SIGNAL TRANSDUCTION; VERAPAMIL;

EID: 42949161096     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2008.00088.x     Document Type: Article

References (50)

1. Litovitz TL, Klein-Schwartz W, White S, et al. 1999 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2000; 18:517-74.
2. Litovitz TL, Klein-Schwartz W, White S, et al. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2001; 19:337-95.
3. Litovitz TL, Smilkstein M, Felberg L, et al. 1996 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1997; 15:447-500.
4. Litovitz TL, Klein-Schwartz W, Dyer KS, et al. 1997 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 1998; 16:443-97.
5. Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2002 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2003; 21:353-421.
6. Lai MW, Klein-Schwartz W, Rodgers GC, et al. 2005 Annual report of the American Association of Poison Control Centers' national poisoning and exposure database. Clin Toxicol (Phila). 2006; 44:803-932.
7. Watson WA, Litovitz TL, Rodgers GC, et al. 2004 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Washington, DC: AAPCC, 2004, pp. 589-666.
8. DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev. 2004; 23:223-8.
9. Ohta M, Nelson J, Nelson D, Meglasson MD, Erecinska M. Effect of Ca++ channel blockers on energy level and stimulated insulin secretion in isolated rat islets of Langerhans. J Pharmacol Exp Ther. 1993; 264:35-40.
10. Tenharmsel A, Holstege C, Louters L. High dose insulin reverses verapamil inhibition of glucose uptake in mouse striated muscle [abstract]. Ann Emerg Med. 2005; 46:S77.
11. Rosen O. After insulin binds. Science. 1987; 237:1452-8.
12. Holstege CP, Kirk MA, Furbee RB, Wermuth ME. Wide complex dysrhythmia in calcium channel blocker overdose responsive to sodium bicarbonate therapy [abstract]. J Toxicol Clin Toxicol. 1998; 36:509.
13. Watson RT, Pessin JE. Bridging the GAP between insulin signaling and GLUT4 translocation. Trends Biochem Sci. 2006; 31:215-22.
14. Cushman SW, Wardzala LJ. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J Biol Chem. 1980; 255:4758-62.
15. Suzuki K, Kono T. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site. Proc Natl Acad Sci U S A. 1980; 77:2542-5.
16. Chang L, Chiang SH, Saltiel AR. TC10alpha is required for insulin-stimulated glucose uptake in adipocytes. Endocrinology. 2007; 148:27-33.
17. Fischer Y, Thomas J, Sevilla L, et al. Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J Biol Chem. 1997; 272:7085-92.
18. Wheeler TJ, Cole D, Hauck MA. Characterization of glucose transport activity reconstituted from heart and other tissues. Biochim Biophys Acta. 1998; 1414:217-30.
19. Cartee GD, Briggs-Tung C, Holloszy JO. Diverse effects of calcium channel blockers on skeletal muscle glucose transport. Am J Physiol. 1992; 263(1 Pt 2):R70-5.
20. Whitehead JP, Molero JC, Clark S, Martin S, Meneilly G, James DE. The role of Ca2+ in insulin-stimulated glucose transport in 3T3-L1 cells. J Biol Chem. 2001; 276:27816-24.
21. Khil LY, Cheon AJ, Chang TS, Moon CK. Effects of calcium on brazilin-induced glucose transport in isolated rat epididymal adipocytes. Biochem Pharmacol. 1997; 54(1):97-101.
22. Anonymous. Part 12: Pediatric Advanced Life Support. Circulation. 2005; 112(24 Suppl I):IV-167-187.
23. Anonymous. Toxicology in ECC. Circulation. 2005; 112(24 Suppl I):IV-126-132.
24. Rubin CS, Hirsch A, Fung C, Rosen OM. Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3-L1 cells. J Biol Chem. 1978; 253:7570-8.
25. Piper R, Hess L, James D. Differential sorting of two glucose transporters expressed in insulin-sensitive cells. Am J Physiol. 1991; 260(3 Pt 1):C570-80.
26. Draznin B, Sussman K, Kao M, Lewis D, Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem. 1987; 262:14385-8.
27. Nedachi T, Kanzaki M. Regulation of glucose transporters by insulin and extracellular glucose in C2C12 myotubes. Am J Physiol Endocrinol Metab. 2006; 291:E817-28.
28. Huang C, Somwar R, Patel N, Niu W, Torok D, Klip A. Sustained exposure of L6 myotubes to high glucose and insulin decreases insulin-stimulated GLUT4 translocation but upregulates GLUT4 activity. Diabetes. 2002; 51:2090-8.
29. Bain J, Plater L, Elliott M, Shpiro N, et al. The selectivity of protein kinase inhibitors: a further update. Biochem J. 2007; 408:297-315.
30. Nakanishi S, Kakita S, Takahashi I, et al. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J Biol Chem. 1992; 267:2157-63.
31. Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, et al. 2001 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2002; 20:391-452.
32. Ardizzone TD, Lu XH, Dwyer DS. Calcium-independent inhibition of glucose transport in PC-12 and L6 cells by calcium channel antagonists. Am J Physiol Cell Physiol. 2002; 283:C579-86.
33. Khil LY, Han SS, Kim SG, et al. Effects of brazilin on GLUT4 recruitment in isolated rat epididymal adipocytes. Biochem Pharmacol. 1999; 58:1705-12.
34. Draznin B, Kao M, Sussman KE. Insulin and glyburide increase cytosolic free-Ca2+ concentration in isolated rat adipocytes. Diabetes. 1987; 36:174-8.
35. Klip A, Ramlal T. Cytoplasmic Ca2+ during differentiation of 3T3-L1 adipocytes. Effect of insulin and relation to glucose transport. J Biol Chem. 1987; 262:9141-6.
36. Bihler I, Sawh PC. Role of calcium influx in the regulation of sugar transport in resting left atrial muscle. Mol Cell Endocrinol. 1980; 19:93-100.
37. Zierath JR, Houseknecht KL, Gnudi L, Kahn BB. High-fat feeding impairs insulin-stimulated GLUT4 recruitment via an early insulin-signaling defect. Diabetes. 1997; 46:215-23.
38. Karnieli E, Moscona R, Rafaeloff R, Illouz YG, Armoni M. Discrepancy between glucose transport and transporters in human femoral adipocytes. Am J Physiol. 1989; 1:E179-85.
39. Konrad D, Bilan PJ, Nawaz Z, et al. Need for GLUT4 activation to reach maximum effect of insulin-mediated glucose uptake in brown adipocytes isolated from GLUT4myc-expressing mice. Diabetes. 2002; 51:2719-26.
40. Klip A, Ramlal T, Bilan PJ, Cartee GD, Gulve EA, Holloszy JO. Recruitment of GLUT-4 glucose transporters by insulin in diabetic rat skeletal muscle. Biochem Biophys Res Commun. 1990; 172:728-36.
41. Bazuine M, Carlotti F, Tafrechi RS, Hoeben RC, Maassen JA. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol. 2004; 18:1697-707.
42. Bazuine M, Carlotti F, Rabelink MJ, Vellinga J, Hoeben RC, Maassen JA. The p38 mitogen-activated protein kinase inhibitor SB203580 reduces glucose turnover by the glucose transporter-4 of 3T3-L1 adipocytes in the insulin-stimulated state. Endocrinology. 2005; 146:1818-24.
43. Bazuine M, Ouwens DM, Gomes de Mesquita DS, Maassen JA. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity. Eur J Biochem. 2003; 270:3891-903.
44. Hwang DY, Ismail-Beigi F. Stimulation of GLUT-1 glucose transporter expression in response to hyperosmolarity. Am J Physiol Cell Physiol. 2001; 281:C1365-72.
45. Fujishiro M, Gotoh Y, Katagiri H, et al. MKK6?3 and p38 MAPK pathway activation is not necessary for insulin-induced glucose uptake but regulates glucose transporter expression. J Biol Chem. 2001; 276:19800-6.
46. Maines MD. Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways. Antioxid Redox Signal. 2007; 9:2187-95.
47. Lerner-Marmarosh N, Shen J, Torno MD, Kravets A, Hu Z, Maines MD. Human biliverdin reductase: a member of the insulin receptor substrate family with serine?threonine?tyrosine kinase activity. Proc Natl Acad Sci U S A. 2005; 102:7109-14.
48. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 1990; 61:203-12.
49. Entingh-Pearsall A, Kahn CR. Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I. J Biol Chem. 2004; 279:38016-24.
50. Soos MA, Whittaker J, Lammers R, Ullrich A, Siddle K. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J. 1990; 270:383-90.